ICD-10 Coding for Sarcoidosis(A15.0, A15.0P, A18.4)
Comprehensive guide on ICD-10 coding for sarcoidosis, including documentation requirements, clinical validation, and common coding pitfalls.
Complete code families applicable to Sarcoidosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D86.0 | Sarcoidosis of lung | Use when sarcoidosis is confirmed in the lungs with appropriate clinical validation. |
|
| D86.3 | Sarcoidosis of skin | Use when sarcoidosis is confirmed in the skin with biopsy evidence. |
|
| D86.81 | Sarcoid meningitis | Use when sarcoidosis involves the meninges with clinical and imaging confirmation. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSarcoidosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Sarcoidosis.
Failing to document exclusion of tuberculosis
Impact
Clinical: Misdiagnosis risk, Regulatory: Non-compliance with coding standards, Financial: Potential claim denials
Mitigation
Always include TB test results, Ensure differential diagnosis is documented
Using unspecified codes when specific organ involvement is documented
Impact
Reimbursement: Lower reimbursement due to unspecified codes, Compliance: Increased audit risk, Data Quality: Decreased accuracy in clinical data
Mitigation
Always specify the organ involved and use the corresponding specific code.
Use of unspecified codes
Impact
High audit risk when specific organ involvement is not documented
Mitigation
Ensure documentation specifies the organ involved and use the corresponding specific code.